XPH icon

SPDR S&P Pharmaceuticals ETF
XPH

Overview Fund Activity

60 hedge funds and large institutions have $84.3M invested in SPDR S&P Pharmaceuticals ETF in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 17 closing their positions.

Holders
60
Holders Change
-12
Holders Change %
-16.67%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
18
Reduced
17
Closed
17
Calls
$366K
Puts
$878K
Net Calls
-$512K
Net Calls Change
-$373K

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$13M
2
Citadel Advisors
2
Citadel Advisors
Florida
$1.89M
3
CI
3
CX Institutional
Indiana
$805K
4
Baird Financial Group
4
Baird Financial Group
Wisconsin
$929K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$1.98M

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$1.01M
2
Morgan Stanley
2
Morgan Stanley
New York
$23.9M
3
HighTower Advisors
3
HighTower Advisors
Illinois
$0
4
Wells Fargo
4
Wells Fargo
California
$2.02M
5
Bank of America
5
Bank of America
North Carolina
$12M
Name Holding Trade Value Shares
Change 		Shares
Change %
SWM
76
Spire Wealth Management
Virginia
– -$1K -15 Closed
TFA
77
Transamerica Financial Advisors
Florida
– -$1K -1 Closed
1 2 3
4